Posted by admin on May 16th, 2022

DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) – Investment analysts at Jefferies Financial Group cut their Q2 2022 earnings per share (EPS) estimates for DENTSPLY SIRONA in a research note issued on Wednesday, May 11th. Jefferies Financial Group analyst B. Couillard now expects that the medical instruments supplier will post earnings of $0.49 per share for the quarter, down from their previous forecast of $0.71. Jefferies Financial Group also issued estimates for DENTSPLY SIRONA’s Q3 2022 earnings at $0.60 EPS, Q4 2022 earnings at $0.76 EPS, FY2022 earnings at $2.37 EPS, Q1 2023 earnings at $0.59 EPS, Q2 2023 earnings at $0.60 EPS, Q3 2023 earnings at $0.65 EPS, Q4 2023 earnings at $0.72 EPS and FY2023 earnings at $2.55 EPS.

XRAY has been the topic of several other reports. The Goldman Sachs Group lowered their target price on shares of DENTSPLY SIRONA from $59.00 to $47.00 and set a “neutral” rating on the stock in a report on Thursday, April 21st. Bank of America cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $66.00 to $49.00 in a research note on Tuesday, April 19th. Morgan Stanley decreased their target price on shares of DENTSPLY SIRONA from $62.00 to $52.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 20th. TheStreet lowered shares of DENTSPLY SIRONA from a “b-” rating to a “c+” rating in a report on Friday, March 18th. Finally, Piper Sandler restated a “neutral” rating and issued a $46.00 target price (down previously from $71.00) on shares of DENTSPLY SIRONA in a report on Wednesday, April 20th. Seven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $52.89.

Shares of XRAY stock opened at $38.23 on Monday. The firm has a 50 day moving average price of $45.69 and a two-hundred day moving average price of $51.13. The company has a quick ratio of 1.12, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $8.24 billion, a PE ratio of 22.62, a price-to-earnings-growth ratio of 2.49 and a beta of 0.94. DENTSPLY SIRONA has a 12-month low of $35.00 and a 12-month high of $69.07.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last released its earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.04). The firm had revenue of $9.67 billion for the quarter, compared to the consensus estimate of $982.05 million. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. DENTSPLY SIRONA’s revenue for the quarter was up 841.1% on a year-over-year basis. During the same quarter last year, the company posted $0.72 EPS.

A number of institutional investors and hedge funds have recently made changes to their positions in XRAY. First Trust Advisors LP raised its stake in DENTSPLY SIRONA by 203.9% during the 1st quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock valued at $4,517,000 after buying an additional 61,111 shares during the last quarter. Amundi Pioneer Asset Management Inc. raised its stake in DENTSPLY SIRONA by 39.9% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock valued at $9,157,000 after buying an additional 52,645 shares during the last quarter. Morgan Stanley increased its stake in shares of DENTSPLY SIRONA by 16.1% in the 2nd quarter. Morgan Stanley now owns 607,754 shares of the medical instruments supplier’s stock worth $38,445,000 after purchasing an additional 84,088 shares in the last quarter. Russell Investments Group Ltd. increased its stake in shares of DENTSPLY SIRONA by 44.8% in the 3rd quarter. Russell Investments Group Ltd. now owns 79,479 shares of the medical instruments supplier’s stock worth $4,620,000 after purchasing an additional 24,587 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in shares of DENTSPLY SIRONA by 1.3% in the 3rd quarter. Principal Financial Group Inc. now owns 274,690 shares of the medical instruments supplier’s stock worth $15,945,000 after purchasing an additional 3,477 shares in the last quarter. Institutional investors and hedge funds own 94.79% of the company’s stock.

In related news, Director Eric Brandt sold 6,900 shares of the company’s stock in a transaction that occurred on Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total value of $273,999.00. Following the transaction, the director now directly owns 35,155 shares of the company’s stock, valued at approximately $1,396,005.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.69% of the company’s stock.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 8th. Investors of record on Friday, March 25th were given a $0.125 dividend. The ex-dividend date was Thursday, March 24th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 1.31%. DENTSPLY SIRONA’s dividend payout ratio is 29.59%.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

EnPro Industries (NYSE:NPO) Lifted to “Buy” at StockNews.com

Wolverine World Wide, Inc. (NYSE:WWW) Forecasted to Post Q2 2022 Earnings of $0.66 Per Share